Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02813876 · ClinicalTrials.gov registry record · Phase 2
Enhanced Recovery in Acute Pancreatitis
A Phase 2 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 2
- Development phase
- 46
- Enrollment target
NCT02813876: Completed Phase 2 study, sponsored by Kaiser Permanente.
NCT02813876 is a Phase 2 study that has completed, run by Kaiser Permanente. The registered enrollment target is 46 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02813876, a Phase 2 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 46 participants
- Enrollment target
Study Summary
Prospective randomized-controlled trial evaluating impact of enhanced recovery protocol compared to standard care for recovery of patients with acute pancreatitis.
Primary Outcome
Resumption of intake of 50% of solid meal without symptoms of worsening post-prandial abdominal pain, nausea or vomiting
Interventions
- OTHER Enhanced recovery protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2016-06 |
| Est. Completion | 2017-05-15 |
| Phase | Phase 2 |
What the finished NCT02813876 record still lists
NCT02813876 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 1 intervention - of which Enhanced recovery protocol is the first listed.
NCT02813876 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02813876 about?
NCT02813876 is a clinical study titled "Enhanced Recovery in Acute Pancreatitis". Prospective randomized-controlled trial evaluating impact of enhanced recovery protocol compared to standard care for recovery of patients with acute pancreatitis.
What is the current status of trial NCT02813876?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 2016-06. Estimated completion is 2017-05-15.
What interventions are being tested in trial NCT02813876?
The interventions under investigation include: Enhanced recovery protocol (OTHER).
Who is sponsoring clinical trial NCT02813876?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02813876's enrollment target sits among peer trials
46 1286th of 2000 higher than 705 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia